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Tobacco industry lobbying undermines public health
in Asia
Industry targets tobacco control policies in Pakistan, India, and Laos
Nicholas S Hopkinson senior lecturer in respiratory medicine 1, Martin McKee professor 2, K Srinath
Reddy professor 3
1NIHR Respiratory Biomedical Research Unit, Royal Brompton and Harefield NHS Foundation Trust and Imperial College London, London SW3
6NP, UK; 2London School of Hygiene and Tropical Medicine, London, UK; 3Public Health Foundation of India, Delhi, India
The implementation of tobacco control measures is a political
choice. Although tobacco control will improve the wellbeing
of the populations that governments serve, the industry spares
no attempt to deter, dilute, or delay effective measures for
tobacco control, be it taxation or prominent pictorial health
warnings. There is troubling evidence that the tobacco industry
is exerting undue influence in several Asian countries, in some
cases with the complicity of governments, to thwart public
health measures.
The case against tobacco is clear. An addiction that usually
starts in childhood,1 smoking is predicted to kill one billion
people in the 21st century,2 with a global social burden costing
an estimated $2.1tn (Rs134tn; £1.4tn; €1.9tn) a year.3Themeans
to prevent this are set out clearly in the World Health
Organization’s 2003 Framework Convention on Tobacco
Control and the associated MPOWER policy framework
(Monitor tobacco use and prevention policies, Protect people
from tobacco smoke, Offer help to quit tobacco use,Warn about
the dangers of tobacco, Enforce bans on tobacco advertising,
promotion and sponsorship, and Raise taxes on tobacco). The
countries that have implemented these measures most
assiduously have seen the greatest falls in smoking rates.4
The framework convention states that there is a “fundamental
and irreconcilable conflict between the tobacco industry’s
interests and public health policy interests.” Article 5.3 of the
convention binds parties to “interact with the tobacco industry
only when and to the extent strictly necessary to enable them
to effectively regulate the tobacco industry and tobacco
products.” This rule is necessary because well documented
industry tactics of lobbying, bullying, and threats of litigation
have delayed and continue to delay measures to reduce uptake
of smoking by children and promote quitting.
Delays to controls
In October 2014 the Indian government announced plans to
mandate the use of pictorial health warnings covering 85% of
tobacco product packaging. This was to come into effect from
1 April 2015. However, a committee of parliamentarians that
had consulted tobacco industry lobbyists successfully
recommended that these plans be suspended.5Although tobacco
is estimated to account for 40% of all cancers in Indian men,6
the committee chair, Dilip Gandhi, made the extraordinary
assertion that no study in India had established that tobacco
causes cancer. “Whether it actually causes cancer or other
diseases is subject to a study in the country. That has never
happened. And the basis of our stance towards tobacco products
are basically studies that have happened in a foreign setting.”5
Senior Indian tax officials are also listed as participants in the
12th annual Asia Pacific tax forum, to be held in Delhi, and
sponsored by four of the global tobacco corporations.7
Understandably, these contacts have faced vigorous opposition
from the Indian public health community.
Pakistan’s Ministry of National Health Services announced in
February 2015 that it would introduce new regulations from the
end of the followingmonth requiring graphic images on cigarette
packages to cover 85% of the packs, up from 40% previously.
Following a meeting called by British American Tobacco,
involving the finance minister and the minister of state for
national health services regulation and coordination, a committee
was constituted to review the regulations, which have now been
delayed until the end of May.
Worryingly, this meeting was attended by the British high
commissioner.8 9 The British government maintains that it had
thought the meeting would cover only issues related to the
business environment in Pakistan and not public health concerns.
This complacency ignores how the tobacco industry makes use
of such meetings to pursue multiple agendas. Arguments that
tobacco control measures, such as price rises or packaging
changes, will affect the “business environment” by facilitating
smuggling or illicit tobacco sales, although a standard industry
approach, have long been discredited, now with evidence from
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Asia that the industry has artificially inflated estimates of illegal
trade to support its arguments.10
The government of Laos has entered into an agreement with
Imperial Tobacco that maintains low levels of tax and allows
the company to negotiate “from time to time, preferential taxes
and duties for the importation of cigarettes and other finished
tobacco products” 11 Tax increases are a major tool for reducing
consumption12 but this agreement means that Laos is unable to
use this powerful approach.
Attempts by the tobacco industry to influence public health
legislation have in the past included engaging prominent
politicians such as the former UK prime minister Margaret
Thatcher,13 and even attempts to develop religious arguments
in favour of tobacco consumption.14 It is important to note that
many Asian countries have a history of progressive tobacco
control policies.15 For example, Singapore banned tobacco
advertising in 1970 and Bhutan prohibits the marketing of all
tobacco products.16However, the examples of lobbying we have
described highlight the importance of strengthening adherence
to the framework convention.17 They also serve as a reminder
of the global nature of the tobacco industry, which must not be
allowed to represent itself as being in favour of “harm
reduction”18 and “social responsibility”19 in one context while
acting with malign ingenuity to obstruct public health in many
others.
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